US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

300.70

+4.391.48%

Post-market: 302.301.60+0.53%19:59 EDT

Volume:214.27K

Turnover:63.36M

Market Cap:578.69M

PE:- -

High:301.50

Open:291.05

Low:289.32

Close:296.31

52wk High:341.93

52wk Low:71.88

Shares:1.92M

Float Shares:1.92M

Volume Ratio:0.59

T/O Rate:11.13%

Dividend:1.01

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Health Care Roundup: Market Talk

Analysts Offer Insights on Healthcare Companies: Innovative Eyewear, Inc. (LUCY) and Irhythm Technologies (IRTC)

Analysts Offer Insights on Healthcare Companies: Annovis Bio (ANVS) and Acurx Pharmaceuticals (ACXP)

HealthCo Healthcare And Wellness REIT (ASX:HCW) Shares Still Lack A Payout Anchor

Simply Wall St.

Max Healthcare Updates NCLT Proceedings Involving Kalinga Hospital Subsidiary

3 Australian AI Healthcare Stocks Building Real Clinical Imaging Tools

Simply Wall St.

Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition

MT Newswires Live

Trump Taps Dr. Heidi Overton to Lead FDA

Trump Nominates Heidi Overton as FDA Commissioner

MT Newswires Live

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (ATAI), InspireMD (NSPR) and Silexion Therapeutics (SLXN)

Trump Nominates Heidi Overton as FDA Commissioner

MT Newswires Live

Trump nominates Dr. Heidi Overton as next FDA Commissioner

Health Care Roundup: Market Talk

Trump: Nominates Dr. Heidi Overton as Next FDA Commissioner

Trump's Truth Social latest posts

Worldwide Healthcare Trust Boosts Treasury Stock in Share Buyback

Why Ryman Healthcare (NZSE:RYM) Is Back In The Spotlight

Simply Wall St.

Alkane Resources Stock Leads These Financially Fit Penny Stocks

Simply Wall St.

Femasys announces FDA approval of FemBloc modular premarket approval application

Teva Pharmaceuticals Says FDA Accepts Ecopipam Filing for Tourette Syndrome

MT Newswires Live

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/LABU/news?page=20"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":300.7,"timestamp":1788292800000,"preClose":296.31,"halted":0,"volume":214265,"hourTrading":{"tag":"盘后","latestPrice":302.3,"preClose":300.7,"latestTime":"19:59 EDT","volume":2272,"amount":684736.992,"timestamp":1788307173491,"change":1.6,"changeRate":0.005321,"amplitude":0.005321},"delay":0,"changeRate":0.014815564780128873,"floatShares":1924486,"shares":1924486,"eps":0,"marketStatus":"Not Yet Opened","change":4.39,"latestTime":"09-01 16:00:00 EDT","open":291.05,"high":301.5,"low":289.32,"amount":63362413.66025,"amplitude":0.041106,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":296.31,"sharesOutstanding":3074486,"nav":296.788,"aum":571163817.07,"dividendRate":0.003351,"bidAskSpread":0.00268,"preHourTrading":{"tag":"盘前","latestPrice":287.9,"preClose":296.31,"latestTime":"09:25 EDT","volume":3856,"amount":1113924.82752,"timestamp":1788269101054,"change":-8.41,"changeRate":-0.028382,"amplitude":0.034741},"postHourTrading":{"tag":"盘后","latestPrice":302.3,"preClose":300.7,"latestTime":"19:59 EDT","volume":2272,"amount":684736.992,"timestamp":1788307173491,"change":1.6,"changeRate":0.005321,"amplitude":0.005321},"volumeRatio":0.594455,"impliedVol":0.9266,"impliedVolPercentile":0.5794},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1924486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.594455,"shares":1924486,"dividePrice":1.0075,"high":301.5,"amplitude":0.041106,"preClose":296.31,"low":289.32,"week52Low":71.88,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":300.7,"eps":0,"divideRate":0.003351,"volume":214265,"delay":0,"ttmEps":0,"open":291.05,"prevYearClose":159.39,"prevWeekClose":295.76,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":335.54,"twentyDayClose":249.47,"sixtyDayClose":160.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:20,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660837475","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2660837475","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660837475?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:50","pubTimestamp":1787172600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1055 ET - The experimental mRNA-based vaccine from Moderna and M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4588","BK4581","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660747308","title":"Analysts Offer Insights on Healthcare Companies: Innovative Eyewear, Inc. (LUCY) and Irhythm Technologies (IRTC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660747308","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660747308?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:30","pubTimestamp":1787171408,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Innovative Eyewear, Inc. (LUCY) and Irhythm Techno...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-innovative-eyewear-inc-lucy-and-irhythm-technologies-irtc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-innovative-eyewear-inc-lucy-and-irhythm-technologies-irtc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0128526141.USD","IRTC","BK4198","BK4137","XLV","HCSG","BK4581","BK4585","BK4588","LU0029874061.USD","LUCY","BK4563","XBI","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660747894","title":"Analysts Offer Insights on Healthcare Companies: Annovis Bio (ANVS) and Acurx Pharmaceuticals (ACXP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660747894","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660747894?lang=en_us&edition=fundamental","pubTime":"2026-08-20 03:40","pubTimestamp":1787168424,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Annovis Bio (ANVS) and Acurx Pharmaceuticals (ACXP) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-annovis-bio-anvs-and-acurx-pharmaceuticals-acxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-annovis-bio-anvs-and-acurx-pharmaceuticals-acxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","ANVS","BK4563","BK4139","BK4585","LU0128526141.USD","BK4588","BK4581","ACXP","BK4539","HCSG","XLV","XBI","LABU","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660476429","title":"HealthCo Healthcare And Wellness REIT (ASX:HCW) Shares Still Lack A Payout Anchor","url":"https://stock-news.laohu8.com/highlight/detail?id=2660476429","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660476429?lang=en_us&edition=fundamental","pubTime":"2026-08-20 03:30","pubTimestamp":1787167831,"startTime":"0","endTime":"0","summary":"HealthCo Healthcare and Wellness REIT came into this result priced for worry, trading at A$0.72 and drifting over the past month even as the long thesis has leaned on hospital-like resilience and infrastructure style income. The headline from these FY26 numbers is not revenue or earnings per share. It is cash flow and distributions.\nFunds from operations, the key measure for real estate investment trusts, was reported at A$0.04 per unit, while underlying look through funds from operations...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9621071-choice2-main-header/1585186711356","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9621071-choice2-main-header/1585186711356"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/real-estate/asx-hcw/healthco-healthcare-and-wellness-reit-shares/news/healthco-healthcare-and-wellness-reit-asxhcw-shares-still-la","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/real-estate/asx-hcw/healthco-healthcare-and-wellness-reit-shares/news/healthco-healthcare-and-wellness-reit-asxhcw-shares-still-la","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XLV","YLDW","BK7149","SRT.SI","XBI","GLS.SI","HCW.AU","BK7156","IQRA","LABU","BPRE","8C8U.SI","DFRA","BK4588","BK4585","RJMG","CLR.SI","JJJ.SI","BK4581","SRU.SI","PSCF","CFA.SI","BK6142","MDIV","IVRA","REIT","RNTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660782420","title":"Max Healthcare Updates NCLT Proceedings Involving Kalinga Hospital Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2660782420","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660782420?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:54","pubTimestamp":1787165698,"startTime":"0","endTime":"0","summary":"Max Healthcare Institute Ltd ( ($IN:MAXHEALTH) ) has provided an announcement. Max Healthcare Institute Ltd is a major private hospital operator in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/max-healthcare-updates-nclt-proceedings-involving-kalinga-hospital-subsidiary?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/max-healthcare-updates-nclt-proceedings-involving-kalinga-hospital-subsidiary?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LABU","BK4581","XBI","BK4137","LU0029874061.USD","XLV","LU0128526141.USD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660764594","title":"3 Australian AI Healthcare Stocks Building Real Clinical Imaging Tools","url":"https://stock-news.laohu8.com/highlight/detail?id=2660764594","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660764594?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:36","pubTimestamp":1787164616,"startTime":"0","endTime":"0","summary":"US 10 year Treasury yields are sitting near multi month highs as investors reassess inflation risks and government borrowing needs. Higher long term rates can pressure broad equity valuations but also push more capital toward companies that aim to cut costs and improve productivity. AI healthcare stocks fit that story. This article walks through three Transformative AI Healthcare Stocks from our screener to help you spot potential long term winners.\nThe stocks covered in the list below are...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-ime/imexhs-shares/news/3-australian-ai-healthcare-stocks-building-real-clinical-ima","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ime/imexhs-shares/news/3-australian-ai-healthcare-stocks-building-real-clinical-ima","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4137","STW.AU","ARTY","ZYAU.AU","SHG.AU","BEAR.AU","OZR.AU","DACE.AU","AYA.AU","EIGA.AU","IIGF.AU","GEAR.AU","VAP.AU","AIPO","IISV.AU","GIVE.AU","LABU","LU0029874061.USD","IME.AU","LU0128526141.USD","QFN.AU","BBOZ.AU","VAS.AU","VGT","BK4581","AGIX","QRE.AU","XBI","XAO.AU","BK4585","XKO.AU","BK7094","TCAF","XJO.AU","IOZ.AU","IMLC.AU","CHAT","E200.AU","CGCV","QTOC","BK4588","VTHR","HCSG","XLV","SLF.AU","OZF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660742032","title":"Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2660742032","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660742032?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:27","pubTimestamp":1787164025,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  has received approval from the US Food and Drug Administration for Pasatru to reduce new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva, or FOP, the drugmaker said Wednesday.FOP is an ultra-rare genetic disorder in which rogue bone formation progressively infiltrates muscles, tendons, ligaments and other connective tissues, causing loss of mobility and potentially making basic activities such as walking, eating and breathing difficult, the company said.The approval was based on phase 3 OPTIMA trial results showing Pasatru reduced new heterotopic ossification lesions by 90% at the 10 mg per kg dose and 94% at the 3 mg per kg dose versus placebo at 56 weeks, the company said.Clinician-assessed flare-ups fell 88% with the 10 mg/kg dose and 15% with the 3 mg per kg dose, the company said.Price: 840.95, Change: +30.71, Percent Change: +3.79","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237438978.USD","BK4585","LU0889565916.HKD","LU0823434583.USD","LU1974910355.USD","LU0058720904.USD","LU0882574055.USD","BBH","LU2362540622.SGD","LU0114720955.EUR","LU2106854487.HKD","LU0320765992.SGD","LABU","LU0289739699.SGD","REGN","LU2468319806.SGD","TBXU","LU1917777945.USD","LU0109394709.USD","BK4588","LU0053666078.USD","IBBQ","LU2023250504.SGD","LU0823434740.USD","IBB","LU2089984988.USD","BK4139","LU2362541513.USD","LU2362541273.HKD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660427749","title":"Trump Taps Dr. Heidi Overton to Lead FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427749?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:03","pubTimestamp":1787162580,"startTime":"0","endTime":"0","summary":"President Trump selected a top White House aide, Dr. Heidi Overton, as his next choice to lead the Food and Drug Administration.  \"She is SMART and RESPECTED by all!Dr. Heidi will work with Secretary Kennedy and Dr. Oz to RAPIDLY deliver on my priorities of FASTER Cures, INCREASED American Innovation, MAJOR Clinical Trial Reforms, LOWER Drug Prices, and even more MAHA WINS!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBB","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660225244","title":"Trump Nominates Heidi Overton as FDA Commissioner","url":"https://stock-news.laohu8.com/highlight/detail?id=2660225244","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660225244?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:37","pubTimestamp":1787157446,"startTime":"0","endTime":"0","summary":"President Donald Trump said Wednesday he has nominated Dr. Heidi Overton as the US Food and Drug Administration Commissioner.\"We need her leadership at the FDA now to ensure that the US remains the WORLD LEADER for Scientific Discovery and CURES,\" Trump said in a post on Truth Social.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660542263","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (ATAI), InspireMD (NSPR) and Silexion Therapeutics (SLXN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660542263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660542263?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:30","pubTimestamp":1787157016,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Atai Beckley N.V. (ATAI), InspireMD (NSPR) and Sil...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-atai-beckley-n-v-atai-inspiremd-nspr-and-silexion-therapeutics-slxn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-atai-beckley-n-v-atai-inspiremd-nspr-and-silexion-therapeutics-slxn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","XBI","NSPR","XLV","BK4588","BK4539","LABU","HCSG","LU0029874061.USD","SLXN","BK4581","LU0128526141.USD","BK4198","BK4139","BK4007","ATAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660422373","title":"Trump Nominates Heidi Overton as FDA Commissioner","url":"https://stock-news.laohu8.com/highlight/detail?id=2660422373","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660422373?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:28","pubTimestamp":1787156901,"startTime":"0","endTime":"0","summary":"Trump Nominates Heidi Overton as FDA Commissioner","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660542236","title":"Trump nominates Dr. Heidi Overton as next FDA Commissioner","url":"https://stock-news.laohu8.com/highlight/detail?id=2660542236","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660542236?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:20","pubTimestamp":1787156411,"startTime":"0","endTime":"0","summary":"President Trump said in a social media post: “Today I am honored to nominate the wonderful Dr. Heidi Overton, MD, PhD, as our next FDA Commissioner...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trump-nominates-dr-heidi-overton-as-next-fda-commissioner-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trump-nominates-dr-heidi-overton-as-next-fda-commissioner-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SOCL","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660228194","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2660228194","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660228194?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:20","pubTimestamp":1787156400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1055 ET - The experimental mRNA-based vaccine from Moderna and M","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4588","XBI","BK4581","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660142283","title":"Trump: Nominates Dr. Heidi Overton as Next FDA Commissioner","url":"https://stock-news.laohu8.com/highlight/detail?id=2660142283","media":"Trump's Truth Social latest posts","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660142283?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:12","pubTimestamp":1787155953,"startTime":"0","endTime":"0","summary":"President Donald Trump on August 19 announced the nomination of Dr. Heidi Overton, MD, PhD, as the next commissioner of the U.S. Food and Drug Administration. In a post on X, Trump praised Overton as...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"724a78f70d7146f1ab07ec048eae1639","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://trumpstruth.org/statuses/41013","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660424236","title":"Worldwide Healthcare Trust Boosts Treasury Stock in Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2660424236","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660424236?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:02","pubTimestamp":1787155357,"startTime":"0","endTime":"0","summary":"Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ) just unveiled an update. Worldwide Healthcare Trust PLC has executed a market purchase of 1,052,58...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-in-share-buyback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-in-share-buyback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4137","LU0029874061.USD","BK4581","BK4588","XLV","LABU","XBI","HCSG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660424022","title":"Why Ryman Healthcare (NZSE:RYM) Is Back In The Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2660424022","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660424022?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:31","pubTimestamp":1787146306,"startTime":"0","endTime":"0","summary":"Ryman Healthcare (NZSE:RYM) is back in focus after director James Miller signalled his intention to step down to prioritise his new role as Chair of the Financial Markets Authority.\nSee our latest analysis for Ryman Healthcare.\nThe recent reshuffle on Ryman Healthcare’s board comes at a time when the share price is around NZ$2.10, with short term share price returns mixed and longer term total shareholder returns still showing a pronounced decline over three and five years. This pattern...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/nz/healthcare/nzx-rym/ryman-healthcare-shares/news/why-ryman-healthcare-nzserym-is-back-in-the-spotlight","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/nz/healthcare/nzx-rym/ryman-healthcare-shares/news/why-ryman-healthcare-nzserym-is-back-in-the-spotlight","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RYM.NZ","BK4585","RYM","BK4588","BK8050","BK4152","BK4581","XLV","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660429545","title":"Alkane Resources Stock Leads These Financially Fit Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660429545","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660429545?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:30","pubTimestamp":1787146240,"startTime":"0","endTime":"0","summary":"US housing data now shows a clear strain from tighter mortgage finance. That pressure can keep many buyers on the sidelines and may push more attention toward the stock market, including Financially Fit Penny Stocks. These are lower priced companies filtered for healthier balance sheets. This article examines three stocks from the screener that some investors use to stay engaged in equities without stretching their budgets.\nThe stocks highlighted below are just a small sample from this...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/alkane-resources-stock-leads-these-financially-fit-penny-sto","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/alkane-resources-stock-leads-these-financially-fit-penny-sto","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XME","BK4535","BK7067","BK4581","BK7501","ALK.AU","XBI","BK7508","SPHQ","XLV","BK7103","BK7104","SIG.AU","MSB.AU","LABU","BK7506","BK4585","UYM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660252964","title":"Femasys announces FDA approval of FemBloc modular premarket approval application","url":"https://stock-news.laohu8.com/highlight/detail?id=2660252964","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660252964?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:16","pubTimestamp":1787145413,"startTime":"0","endTime":"0","summary":"Femasys (FEMY) announced that the FDA has approved the company’s modular premarket approval application pathway for FemBloc, its investigational no...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/femasys-announces-fda-approval-of-fembloc-modular-premarket-approval-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/femasys-announces-fda-approval-of-fembloc-modular-premarket-approval-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","TECB","GNMX","PINK","GDOC","IBB","BK4584","FRTY","MRNX","IEIH","NVIB","BMED","BK4539","MRNY","BK4585","BK4588","IYH","BK4082","XLVX","BBP","LABU","IDNA","FEMY","MEDI","RSPH","SYNB","PSCH","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660624425","title":"Teva Pharmaceuticals Says FDA Accepts Ecopipam Filing for Tourette Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2660624425","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660624425?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:10","pubTimestamp":1787145009,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries'  US affiliate Teva Pharmaceuticals said Wednesday the US Food and Drug Administration has accepted its new drug application for ecopipam to potentially treat children with Tourette syndrome.The regulator has set a target action date for late in Q1 of 2027, the company said.The application is supported by phase 2b and phase 3 data, which showed a reduction in tic severity and sustained efficacy, Teva said.Teva Pharmaceutical Industries shares were up 1.8% in premarket activity Wednesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4596","BK4584","BK4557","BK4585","BK4588","LU2324357040.USD","BK4566","LABU","TEVA","LU1983299246.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421466","title":"U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421466","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421466?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:30","pubTimestamp":1787142600,"startTime":"0","endTime":"0","summary":"Ecopipam(EBS-101) is a first-in-class selective D1 (dopamine) receptor antagonist with Orphan Drug designationNDA acceptance is supported by positive Phase 3 data, which were published in JAMA Neurolo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/19/3347619/0/en/u-s-fda-accepts-teva-s-new-drug-application-nda-and-grants-priority-review-for-ecopipam-a-first-in-class-investigational-therapy-for-pediatric-patients-with-tourette-syndrome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4157","LABU","AIMS","BK4585","LU0566484027.USD","ECG","BK4129","LU1559883803.SGD","BMI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":20,"totalSize":411,"code":"91000000","status":"200"}]}}